Results 161 to 170 of about 37,987 (275)

Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
In Chinese patients with moderate to severe plaque psoriasis, bimekizumab treatment was well tolerated and led to significantly higher clinical response rates versus placebo, including complete skin clearance. These findings were consistent with global studies and suggest that bimekizumab is an effective treatment option for Chinese people living with ...
Lin Cai, Xiao‐Yong Man, Jinyan Wang, Aihua Wei, Ying Chen, Delphine Deherder, Jun Gao, Bengt Hoepken, Weiwei Sun, Tingting Lei, Jianzhong Zhang, the BE SHINING Study Group   +11 more
wiley   +1 more source

Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis. [PDF]

RMD Open, 2020
den Braanker H, Wervers K, Mus AMC, Bangoer PS, Davelaar N, Luime J, Tchetverikov I, Hazes JMW, Vis M, Lubberts E, Kok MR.   +10 more
europepmc   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial. [PDF]

Rheumatology (Oxford), 2020
Coates LC, Mahmood F, Freeston J, Emery P, Conaghan PG, Helliwell PS.   +5 more
europepmc   +1 more source

Inflammatory osteolysis: A conspiracy against bone [PDF]

, 2017
Abu-Amer, Abu-Amer, Anton, Bardin, Beranger, Chen, Christo, Claro, Cobelli, Coll, Dapunt, Deborah V. Novack, Dewhirst, Gabriel Mbalaviele, Georg Schett, Gravallese, Harre, Josse, Jovanovic, Kollias, Lukens, Maitra, McCall, Mukai, Negishi-Koga, Osta, Ozen, Pasco, Robaszkiewicz, Rubbert-Roth, Sanchez, Scianaro, Sharma, Steven L. Teitelbaum, Van Hauwermeiren, Wang, Zaki   +36 more
core   +2 more sources

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Weiyu Ye, Niamh Dooley, Wei Ren Tan, Bolaji Coker, Teresa Tsakok, Lucy Moorhead, Jade Pizzato, Kingsley Powell, Madeline Kroah‐Hartman, Alexandra Paolino, Treasa Jiang, Freya Jackson‐Duffy, John Y. W. Lee, Manpreet K. Sagoo, Georgia Sewell, Camille Lancelot, Helen McAteer, John Weinman, Jonathan N. Barker, Sarah Chapman, Sam Norton, Catherine H. Smith, Satveer K. Mahil   +22 more
wiley   +1 more source

GATA3 Deletion Associated With Juvenile Idiopathic Arthritis: Expanding the Phenotypic Spectrum of Hypoparathyroidism, Sensorineural Deafness, and Renal Dysplasia (HDR) Syndrome

American Journal of Medical Genetics Part A, Volume 200, Issue 3, Page 733-737, March 2026.
ABSTRACT Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome is caused by pathogenic variants in the GATA3 gene located on chromosome 10p14. Here we present a 10‐year‐old girl with HDR syndrome who also has oligoarticular juvenile idiopathic arthritis (JIA).
Lauren N. Meiss, Amanda V. Karam, Julia Shalen, David E. Tunkel, Belina Y. Yi, Kelsey S. Guthrie, Emily M. Kudalkar, Anna E. Patrick, Sonja A. Rasmussen   +8 more
wiley   +1 more source

Bioactive Phytochemical Compounds in Medicago sativa L. (Alfalfa): A Systematic Review of Biological Properties and Therapeutic Relevance in Nutraceutical and Functional Food Implications

Food Frontiers, Volume 7, Issue 2, March 2026.
ABSTRACT Medicago sativa L. (alfalfa) harbors a remarkably diverse reservoir of bioactive secondary metabolites. Flavonoids, isoflavones, and triterpenoid saponins dominate its bioactivity landscape, driving potent antioxidant, anti‐inflammatory, antimicrobial, estrogenic, hypolipidemic, and cytotoxic actions through redox modulation, membrane ...
Parham Joolaei Ahranjani, Hamid Rashidi Nodeh, Zahra Esfandiari, Giovanna Ferrentino   +3 more
wiley   +1 more source

Utility of the Siriraj Psoriatic Arthritis Screening Tool, the Thai Psoriasis Epidemiology Screening Tool, and the Early Arthritis for Psoriatic Patients Questionnaire to Screen for Psoriatic Arthritis in an Outpatient Dermatology Clinic Setting, and Identification of Factors Significantly Associated with Psoriatic Arthritis

Siriraj Medical Journal, 2019
Objective: To assess the clinical utility of the Psoriasis Epidemiology Screening Tool (PEST), the Early Arthritis for Psoriatic Patients (EARP) questionnaire, and the Siriraj Psoriatic Arthritis Screening Tool (SiPAT) as screening tools for psoriatic ...
Leena Chularojanamontri, Natchaya Junsuwan, Narumol Silpa-archa, Chanisada Wongpraparut, Praveena Chiowchanwisawakit   +4 more
doaj  

Australian Podiatry Research in Rheumatology: A Bibliometric Analysis

Journal of Foot and Ankle Research, Volume 19, Issue 1, March 2026.
ABSTRACT Background To conduct a bibliographic analysis of English language foot and ankle research pertaining to rheumatology published by Australian authors. Methods The Scopus database search was conducted to identify all Australian rheumatology articles published by podiatric authors in English from 1970 to 2024. Bibliometric analysis was performed
Shan M. Bergin, Polly Q. X. Lim, Hylton B. Menz, Peta E. Tehan, Matthew R. Carroll   +4 more
wiley   +1 more source